PARP1 and glioblastoma: We retrieved this dataset and confirmed no significant difference in PARP-1 mean gene expression between the clinically relevant 5ALA positive invasive GBM sub-population(s), and all intra-tumor regions and 5ALA negative sub-population(s) (p-value 0.58) (Fig. 1c).